Pacemaker Market Analysis, Top Companies, New Technology, Demand and Opportunity Analysis
A pacemaker
is a small device that is placed in chest or abdomen, which uses electrical
pulses to maintain adequate heartbeat. Increasing prevalence of heart diseases
and growing geriatric population are positively impacting the growth of the
global pacemaker market. According to the Centers for Disease Control and
Prevention (CDC) statistics 2017, 2.7–6.1 million people in the U.S. had atrial
fibrillation. It is the most common type of abnormal heart rhythm. Although,
arrhythmia affects all age groups, however, risk of developing atrial
fibrillation increases significantly with age.
Based on technology, the pacemaker market is categorized
into single-chamber, dual-chamber, and biventricular. Single-chamber pacemaker
connects the pulse generator to one of the chambers of heart. Dual-chamber
pacemaker comprises two leads, which are placed in the right atrium and
ventricle. Biventricular pacemaker consists of two or three leads and is used
in patient that shows a lack of synchronization between contractions of the
left and right ventricles, which is a most common condition, known as
ventricular desynchrony.
On the basis of application, the pacemaker
market is categorized into arrhythmia, atrial fibrillation, heart
block, and long QT syndrome. Based on end user, the pacemaker industry is
classified into cardiac clinics, hospitals, and ambulatory surgical centers.
Pacemaker devices in hospitals are expected to lead the market, due to increase
in the prevalence of heart diseases and surging number of patients undergoing
surgeries in hospitals. According to CDC, more than 750,000 hospitalizations
cases occur each year due to atrial fibrillation.
Request to Get the Sample Pages at:
The pacemaker industry is characterized by increasing number
of product launches and collaborations that leads to the expansion of
manufacturers’ market share. For instance, Biotronik Inc. launched Edora
Pacemaker Series with Magnetic Resonance Imaging (MRI) AutoDetect Technology in
2017. It is the smallest MR-conditional pacemaker with automated MRI detection
capability available in the U.S. with a volume of 10 cc and weight of 20.8 g.
In 2018, Bay Labs Inc., a medical technology company at the
forefront of applying artificial intelligence (AI) for cardiovascular imaging,
announced a collaboration with Edwards Lifesciences Corporation to focus on
improving the detection of heart diseases. The companies believe that this will
help in the early detection and treatment of the diseases.
Some other major players in the global pacemaker market are
Abbott Inc. (ST. Jude Medical), Medtronic PLC, Boston Scientific Corporation,
Sorin Group, Lepu Medical Co. Ltd., Zoll Medical Corporation, and Medico SpA.
The study provides the historical as well the forecast
market size data for various countries including the U.S., Canada, France,
Germany, the U.K., Italy, Spain, Japan, China, India, Brazil, Saudi Arabia, and
South Africa.
Comments
Post a Comment